Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel A Gonzalez

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
American Heart Journal|June 24, 2010
Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Cédric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 29, 2011
Reliability using the universal classification of acute myocardial infarction compared to ST-segment classificationManuel A Gonzalez, Rana A Marzouq, Summiyah Nasir, et al.
Hormones and Behavior|January 22, 2022
Territorial scent-marking effects on vigilance behavior, space use, and stress in female Columbian ground squirrelsJeffrey D Roth, F Stephen Dobson, Peter Neuhaus, et al.
The American Journal of Cardiology|January 28, 2010
Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary interventionCedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, et al.
The American Journal of Cardiology|May 25, 2010
Prognosis of asymptomatic coronary artery disease after percutaneous coronary interventionKohei Wakabayashi, Cedric Delhaye, Gabriel Maluenda, et al.
The American Journal of Cardiology|March 10, 2010
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomesMichael A Gaglia, Rebecca Torguson, Nicholas Hanna, et al.
The American Journal of Cardiology|July 21, 2010
Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionKohei Wakabayashi, Manuel A Gonzalez, Cedric Delhaye, et al.
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Insurance type influences the use of drug-eluting stentsMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
American Heart Journal|June 24, 2010
Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Cédric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 29, 2011
Reliability using the universal classification of acute myocardial infarction compared to ST-segment classificationManuel A Gonzalez, Rana A Marzouq, Summiyah Nasir, et al.
Hormones and Behavior|January 22, 2022
Territorial scent-marking effects on vigilance behavior, space use, and stress in female Columbian ground squirrelsJeffrey D Roth, F Stephen Dobson, Peter Neuhaus, et al.
The American Journal of Cardiology|January 28, 2010
Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary interventionCedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, et al.
The American Journal of Cardiology|May 25, 2010
Prognosis of asymptomatic coronary artery disease after percutaneous coronary interventionKohei Wakabayashi, Cedric Delhaye, Gabriel Maluenda, et al.
The American Journal of Cardiology|March 10, 2010
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomesMichael A Gaglia, Rebecca Torguson, Nicholas Hanna, et al.
The American Journal of Cardiology|July 21, 2010
Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionKohei Wakabayashi, Manuel A Gonzalez, Cedric Delhaye, et al.
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Insurance type influences the use of drug-eluting stentsMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
Pageof 5